Vijender Panduga

1.2k total citations
8 papers, 244 citations indexed

About

Vijender Panduga is a scholar working on Infectious Diseases, Molecular Biology and Pharmacology. According to data from OpenAlex, Vijender Panduga has authored 8 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Vijender Panduga's work include Tuberculosis Research and Epidemiology (5 papers), Cancer therapeutics and mechanisms (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Vijender Panduga is often cited by papers focused on Tuberculosis Research and Epidemiology (5 papers), Cancer therapeutics and mechanisms (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Vijender Panduga collaborates with scholars based in India, United Kingdom and United States. Vijender Panduga's co-authors include Jitendar Reddy, Sreevalli Sharma, Suresh Solapure, Radha Krishan Shandil, Vasanthi Ramachandran, Samit Ganguly, Naveen Kumar, V. Balasubramanian, Ramanatha Saralaya and Vijay Kamal Ahuja and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, International Journal of Pharmaceutics and British Journal of Clinical Pharmacology.

In The Last Decade

Vijender Panduga

8 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vijender Panduga India	7	143	111	76	59	42	8	244
Jitendar Reddy India	7	153 1.1×	116 1.0×	80 1.1×	58 1.0×	40 1.0×	9	255
Daniel Hoagland United States	7	174 1.2×	282 2.5×	84 1.1×	83 1.4×	29 0.7×	7	444
Ana Ribeiro Italy	11	253 1.8×	241 2.2×	152 2.0×	88 1.5×	66 1.6×	15	458
Béatrice Silvia Orena Italy	10	93 0.7×	156 1.4×	49 0.6×	92 1.6×	17 0.4×	18	304
Mel Spigelman United States	6	272 1.9×	142 1.3×	171 2.3×	57 1.0×	24 0.6×	11	376
Hwankyu Kang South Korea	5	103 0.7×	94 0.8×	60 0.8×	72 1.2×	17 0.4×	9	205
Arianna D. Pranger Netherlands	7	146 1.0×	58 0.5×	118 1.6×	24 0.4×	42 1.0×	9	294
Nagamiah Selvakumar India	5	164 1.1×	96 0.9×	112 1.5×	34 0.6×	22 0.5×	6	260
Hee Kyoung Jeon South Korea	7	106 0.7×	119 1.1×	47 0.6×	29 0.5×	17 0.4×	8	196
Marisa Vescovo Argentina	7	199 1.4×	76 0.7×	137 1.8×	29 0.5×	32 0.8×	8	258

Countries citing papers authored by Vijender Panduga

Since Specialization

Citations

This map shows the geographic impact of Vijender Panduga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vijender Panduga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vijender Panduga more than expected).

Fields of papers citing papers by Vijender Panduga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vijender Panduga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vijender Panduga. The network helps show where Vijender Panduga may publish in the future.

Co-authorship network of co-authors of Vijender Panduga

This figure shows the co-authorship network connecting the top 25 collaborators of Vijender Panduga. A scholar is included among the top collaborators of Vijender Panduga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vijender Panduga. Vijender Panduga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Panduga, Vijender, Karin Nelander, Maria Heijer, et al.. (2024). A drug–drug interaction study and physiologically based pharmacokinetic modelling to assess the effect of an oral 5‐lipoxygenase activating protein inhibitor on the pharmacokinetics of oral midazolam. British Journal of Clinical Pharmacology. 90(9). 2180–2187. 1 indexed citations

Panduga, Vijender, Michael J. Stocks, & Cynthia Bosquillon. (2017). Ipratropium is ‘luminally recycled’ by an inter-play between apical uptake and efflux transporters in Calu-3 bronchial epithelial cell layers. International Journal of Pharmaceutics. 532(1). 328–336. 11 indexed citations

Singh, Ragini, Vasanthi Ramachandran, Radha Krishan Shandil, et al.. (2015). In Silico -Based High-Throughput Screen for Discovery of Novel Combinations for Tuberculosis Treatment. Antimicrobial Agents and Chemotherapy. 59(9). 5664–5674. 8 indexed citations

P, Shahul Hameed, Anandkumar Raichurkar, Prashanti Madhavapeddi, et al.. (2014). Benzimidazoles: Novel Mycobacterial Gyrase Inhibitors from Scaffold Morphing. ACS Medicinal Chemistry Letters. 5(7). 820–825. 43 indexed citations

Chatterji, Monalisa, Radha Krishan Shandil, M. R. Manjunatha, et al.. (2014). 1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis. Antimicrobial Agents and Chemotherapy. 58(9). 5325–5331. 89 indexed citations

Hosagrahara, Vinayak, et al.. (2013). Effect of repeated dosing on rifampin exposure in BALB/c mice. European Journal of Pharmaceutical Sciences. 49(1). 33–38. 12 indexed citations

Solapure, Suresh, Neela Dinesh, Radha Krishan Shandil, et al.. (2013). In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 57(6). 2506–2510. 61 indexed citations

Balasubramanian, V., Suresh Solapure, Kunal Kumar, et al.. (2012). Effect of Coadministration of Moxifloxacin and Rifampin on Mycobacterium tuberculosis in a Murine Aerosol Infection Model. Antimicrobial Agents and Chemotherapy. 56(6). 3054–3057. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact